Skip to content
Heart Matters cover art

All episodes

Heart Matters, 232 episodes. Page 1 of 3.

#
Title
1

Examining the Link Between Surgical Menopause and Heart Failure

2

Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery

3

Improving ATTR-CM Care Through Community-Specialist Partnership

4

Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence

5

Exploring AI-Powered ATTR-CM Detection

6

Advancing ATTR-CM Identification: Early Findings from TRACE-AI

7

Anticoagulation Reversal Decisions in Cardiothoracic Surgery: Case-Based Insights

8

Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia

9

A More Complete View of Cardiovascular Risk in Women

10

Updated AACE Guidance on Managing Dyslipidemia in T2D

11

Complication-Centric Diabetes Care: Addressing Obesity and Cardiometabolic Risk

12

Applying Guideline Recommendations to ACS Management

13

Overcoming Challenges in ATTR-CM Diagnosis

14

Multidisciplinary Care in ATTR-CM: Building the Right Team

15

Building Clinical Expertise in ATTR-CM Management

16

The Future of ATTR-CM Care: A Look at What's Next

17

Managing Acute PE: Updates from the 2026 AHA/ACC Guideline

18

From Goals to Action: Multisociety Guidance on Lipid Management

19

Managing Dyslipidemia: 2026 ACC/AHA Guideline Updates

20

How PCSK9 Inhibition Lowers LDL Cholesterol

21

Enlicitide for LDL-C Management: Insights from CORALreef Lipids

22

Risk Prediction with the PREVENT-ASCVD Equations

23

The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice

24

Evaluating ASCVD Risk with the CPR Framework

25

Looking Ahead in ATTR-CM Care: Improving Diagnosis, Outcomes, and Equity

26

Hypertension in Women: Cardiovascular Risk Across the Lifespan

27

Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies

28

Diagnosing ATTR-CM: Recent Advances and Future Directions

29

When to Suspect ATTR-CM: Clues for Earlier Diagnosis

30

Understanding the Mechanisms Behind Resistant Hypertension

31

Quality of Life Conversations in ATTR-CM Care

32

Hypertension Across Diverse Populations: Practical Strategies for Equitable Care

33

Cardiometabolic Considerations in Familial Chylomicronemia Syndrome

34

Advances in Sports Cardiology: Updates from ACC 2026

35

Supporting Patients With ATTR-CM: Preserving Function and Quality of Life

36

Counseling Patients on Disease Progression in ATTR-CM

37

AI-Driven Advances in ATTR-CM Care

38

Redefining ATTR Treatment: Key Mechanisms and Emerging Data

39

Advances in ATTR-CM: Evolving Diagnostics and Therapeutics

40

Treating ATTR-CM Early: A Shift From Reactive to Strategic Care

41

Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025

42

Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health

43

Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control

44

Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control

45

Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health

46

Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk

47

Gender Bias and Heart Health: Improving Cardiovascular Care for Women

48

Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches

49

Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options

50

Improving Lipid Management Through Equity-Focused Clinical Strategies

51

Optimizing Cardiovascular Outcomes in Hyperlipidemia Through Risk-Based Care

52

How Artificial Sweeteners Could Be Linked to Heart Disease

53

Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link

54

Active Aging: Preventing Heart Failure in Older Women with Exercise

55

AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD

56

Pharmacist-Prescribing and Hypertension Management: An Economic Benefit

57

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

58

A Discussion on Statins to Lower CVD Risk for HIV Patients

59

A Discussion on the Updated Recommendations for Managing Dyslipidemia in Adults

60

Identifying Cardiovascular Risk Factors for HIV Patients

61

Exploring Emerging Non-Statin LDL Lowering Therapies

62

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials

63

Stanford Surgeons Perform First Beating-Heart Procedure

64

Treating Tricuspid Valve Regurgitation With Novel Replacement Device

65

Exploring the Use of AI to Detect HFpEF

66

Updates from ACC 2023: Examining Transcatheter Repair Study Data

67

Cardio-Oncology: Key Clinical Data from ACC.23

68

The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team

69

The STELLAR Trial: Key Data on Sotatercept for PAH

70

A Look at Lipoprotein(a): Key Screening & Treatment Strategies

71

Anticipated Updates on Statin Intolerance at ACC 2023

72

The Role of Implementation Science in Familial Hypercholesterolemia

73

Updated Guidelines for Youth With Dyslipidemia

74

A Look into the Effectiveness of Dietary Supplements

75

Uncovering the Results of the DELIVER Trial

76

Exploring Novel Tools for PAH: Measuring Severity with a New Blood Test

77

Investigating the Link Between PCOS & CV Risk Factors During Delivery

78

When Climate & Cardiology Overlap: How Climate Change Can Impact Heart Health

79

The miniPUMP: A New Way to Get a Close-Up View of the Heart

80

Improving Adherence Among HF Patients: A Look at the PROMPT-HF Trial

81

What the SODIUM-HF Trial Means for Heart Failure Patients

82

Breaking Down the Criteria for Iron Deficiency in Heart Failure

83

Reviewing the Role of SGLT2 Inhibitors in Heart Failure

84

Looking into Long-Term Cardiovascular Impacts of COVID-19

85

Cardio-Obstetrics: Taking Better Care of Our Pregnant & Postpartum Patients

86

Exploring Xenotransplantation: Is the Future of Heart Transplants Now?

87

One Foundation's Approach to Preventing Sudden Cardiac Death in Young Athletes

88

Ejection Fraction in Heart Failure: Does It Matter?

89

Cardiac Rehabilitation: Key Considerations for Breast Cancer Survivors

90

Diving into Diversity: A Look at Representation in Cardiovascular Clinical Trials

91

Patching Up Cardiovascular Risk

92

Coronary Heart Disease & Postmenopausal Women: Evaluating Risk Through Research

93

Considering Cannabis & the Cardiovascular System: A Look at Patient Outcomes

94

Exploring the Careers of Cardiologists: A Noninvasive Cardiologist's Journey & a First-Year Student's Story

95

Examining Coronary Heart Disease & Psychosocial Stressors

96

Cardiovascular Complications & Pregnancy: What Cardiologists Need to Know

97

How Can Space Travel Affect Our Heart Health?

98

Investigating the Relationship Between Pregnancy Complications & Coronary Disease

99

ASCVD Risk & Women: Investigating Impact on Female Patients

100

Spotlighting Excellence in Cardiology Care Amid the COVID-19 Pandemic